SEC Form 4 · accession 0001437749-17-004822
BIO KEY INTERNATIONAL INC · BKYI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Schoenherr
Director
Period of report
Mar 15, 2017
Accepted (ET)
Mar 17, 2017 · 4:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001019034
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 15, 2017 | A | 379 | $0.00 | A | 6,078 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $2.64 | Mar 15, 2017 | A | 10,000 | A | — | Mar 14, 2024 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1The option vests in three equal annual installments on March 15, 2018, 2019, and 2020.